February 12, 2024
VIA EDGAR AND ELECTRONIC MAIL
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Joe McCann, Esq. |
| Office of Life Sciences |
| Re: | OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-271034) |
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statements to 5:00 p.m., Eastern time, on Wednesday, February 14, 2024, or as soon as practicable thereafter.
Please advise the undersigned of the effectiveness of the Registration Statements.
| Very truly yours, | |
/s/ Spencer G. Feldman | |
| Spencer G. Feldman |
| cc: | Jimmy McNamara, Esq. Paul A. Romness, MPH |
February 12, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Joe McCann, Esq. |
| Office of Life Sciences |
| Re: | OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-271034) |
Ladies and Gentlemen:
OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statements be accelerated so that they will become effective at 5:00 p.m., Eastern time, on Wednesday, February 14, 2024, or as soon as practicable thereafter.
| Very truly yours, | ||
| OS Therapies Incorporated | ||
| By: | /s/ Paul A. Romness | |
| Paul A. Romness | ||
| President and Chief Executive Officer | ||